KCP
GMED icon

Kera Capital Partners’s Globus Medical GMED Stock Holding History

Kera Capital Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Buy
6,250
+3,265
+109% +$278K 0.05% 325
2026
Q1 		$257K Buy
2,985
+754
+34% +$67.7K 0.03% 474
2025
Q4 		$202K Buy
+2,231
New +$169K 0.03% 533

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Kera Capital Partners's GMED Position: Q2 2026 in Review

Kera Capital Partners increased its Globus Medical (GMED) stake by 109% in Q2 2026, buying an estimated $278K and bringing the position to 6,250 shares worth $494K. The position accounts for 0.05% of the portfolio, ranked #325.

Kera Capital Partners first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Kera Capital Partners held 6,250 shares of Globus Medical worth $494K as of Q2 2026.
  • Kera Capital Partners bought 3,265 Globus Medical shares in Q2 2026, an estimated $278K.
  • Globus Medical made up 0.05% of Kera Capital Partners's portfolio in Q2 2026, its #325 holding.
  • Kera Capital Partners first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.